Skip to content
drillr.ai
Sign up

HALO

Halozyme Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$110.13
−0.57%
Ask drillr
0
Insider buys (3m)
17
Insider sells (3m)
-$7.3M
Net value (3m)
+53.6%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Sep 2, 2026Appelhans Dannielle · directorA-Award1,161$0.00
Sep 2, 2026Appelhans Dannielle · directorA-Award1,778$108
Aug 19, 2026Torley Helen · director, officer: PRESIDENT AND CEOM-Exempt20,000$18
Aug 19, 2026Torley Helen · director, officer: PRESIDENT AND CEOSale5,703$103
Aug 19, 2026Torley Helen · director, officer: PRESIDENT AND CEOSale9,600$107
Aug 19, 2026Torley Helen · director, officer: PRESIDENT AND CEOSale4,897$104
Aug 19, 2026Torley Helen · director, officer: PRESIDENT AND CEOSale900$99
Aug 19, 2026Torley Helen · director, officer: PRESIDENT AND CEOSale500$100
Aug 19, 2026Torley Helen · director, officer: PRESIDENT AND CEOSale7,500$103
Aug 19, 2026Torley Helen · director, officer: PRESIDENT AND CEOSale2,100$102
Aug 19, 2026Torley Helen · director, officer: PRESIDENT AND CEOSale9,400$105
Aug 19, 2026Torley Helen · director, officer: PRESIDENT AND CEOSale3,200$108
Aug 19, 2026Torley Helen · director, officer: PRESIDENT AND CEOSale9,000$103
Aug 19, 2026Torley Helen · director, officer: PRESIDENT AND CEOSale7,200$106
Aug 11, 2026Connaughton Bernadette · directorSale1,626$103
Jul 9, 2026Torley Helen · director, officer: PRESIDENT AND CEOSale1,035$80
Jul 9, 2026Torley Helen · director, officer: PRESIDENT AND CEOSale888$79
Jul 9, 2026Torley Helen · director, officer: PRESIDENT AND CEOM-Exempt1,923$12
Jul 2, 2026Connaughton Bernadette · directorSale625$77
Jul 2, 2026Connaughton Bernadette · directorSale1,000$76
Jul 2, 2026RAMSAY DAVID A · officer: EVP, PRESIDENT, DRUG DELIVERYA-Award16,232$0.00
Jul 2, 2026Snellgrove Darren · officer: SVP, Chief Financial OfficerA-Award127,432$77
Jul 2, 2026RAMSAY DAVID A · officer: EVP, PRESIDENT, DRUG DELIVERYF-InKind5,408$78
Jul 2, 2026RAMSAY DAVID A · officer: EVP, PRESIDENT, DRUG DELIVERYM-Exempt10,000$0.00
Jul 2, 2026Snellgrove Darren · officer: SVP, Chief Financial OfficerA-Award41,554$0.00
Jul 2, 2026RAMSAY DAVID A · officer: EVP, PRESIDENT, DRUG DELIVERYA-Award39,823$77
Jun 30, 2026Krishnan Mahesh · directorSale7,304$75
Jun 30, 2026Krishnan Mahesh · directorM-Exempt7,304$38
Jun 15, 2026Snyder Mark Howard · officer: SVP, CHIEF LEGAL OFFICERF-InKind2,715$70
Jun 15, 2026Snyder Mark Howard · officer: SVP, CHIEF LEGAL OFFICERM-Exempt5,034$0.00
Institutional positioning

13F filings over the trailing two quarters

New 207Increased 504Reduced 429Sold out 69
FilerActionSharesFiled
BlackRock, Inc.Increased13,271,095Aug 7, 2026
BLACKROCK, INC.Increased13,265,053May 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased5,351,312Aug 13, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCIncreased5,299,008Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position5,271,218May 15, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position5,249,206May 8, 2026
STATE STREET CORPIncreased5,179,434Aug 7, 2026
STATE STREET CORPReduced4,937,854May 15, 2026
INVESCO LTD.Increased4,012,494May 12, 2026
Invesco Ltd.Reduced3,177,997Aug 14, 2026
BANK OF AMERICA CORP /DE/Increased2,913,109May 18, 2026
MORGAN STANLEYIncreased2,832,594Aug 13, 2026
Boston PartnersIncreased2,773,568Aug 4, 2026
BANK OF AMERICA CORP /DE/Reduced2,740,561Aug 14, 2026
BOSTON PARTNERSIncreased2,683,683May 11, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 2, 2026